SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001567619-17-000842
Filing Date
2017-04-28
Accepted
2017-04-28 16:45:28
Documents
5
Period of Report
2017-06-20
Effectiveness Date
2017-04-28

Document Format Files

Seq Description Document Type Size
1 DEF 14A s001669x1_def14a.htm DEF 14A 440177
2 s001669x1_proxy1.jpg GRAPHIC 175419
3 s001669x1_proxy2.jpg GRAPHIC 176033
4 s001669x1_proxy3.jpg GRAPHIC 104590
5 s001669x1_proxy4.jpg GRAPHIC 108484
  Complete submission text file 0001567619-17-000842.txt   1195894
Mailing Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922
Business Address 300 CONNELL DRIVE SUITE 4000 BERKELEY HEIGHTS NJ 07922 800-208-3343
Edge Therapeutics, Inc. (Filer) CIK: 0001472091 (see all company filings)

IRS No.: 264231384 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37568 | Film No.: 17796418
SIC: 2834 Pharmaceutical Preparations